CN117396201A - 淋病奈瑟氏菌感染的治疗方法和材料 - Google Patents

淋病奈瑟氏菌感染的治疗方法和材料 Download PDF

Info

Publication number
CN117396201A
CN117396201A CN202280024693.0A CN202280024693A CN117396201A CN 117396201 A CN117396201 A CN 117396201A CN 202280024693 A CN202280024693 A CN 202280024693A CN 117396201 A CN117396201 A CN 117396201A
Authority
CN
China
Prior art keywords
infection
compound
group
groups
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280024693.0A
Other languages
English (en)
Chinese (zh)
Inventor
P·V·拉马钱德兰
M·赛里姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of CN117396201A publication Critical patent/CN117396201A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202280024693.0A 2021-03-26 2022-03-23 淋病奈瑟氏菌感染的治疗方法和材料 Pending CN117396201A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166309P 2021-03-26 2021-03-26
US63/166,309 2021-03-26
PCT/US2022/021467 WO2022204231A2 (en) 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection

Publications (1)

Publication Number Publication Date
CN117396201A true CN117396201A (zh) 2024-01-12

Family

ID=83398108

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280024693.0A Pending CN117396201A (zh) 2021-03-26 2022-03-23 淋病奈瑟氏菌感染的治疗方法和材料

Country Status (8)

Country Link
US (1) US20250339401A1 (cg-RX-API-DMAC7.html)
EP (1) EP4313040A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024511945A (cg-RX-API-DMAC7.html)
KR (1) KR20230161962A (cg-RX-API-DMAC7.html)
CN (1) CN117396201A (cg-RX-API-DMAC7.html)
AU (1) AU2022244356A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204231A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150719A1 (en) * 2022-02-03 2023-08-10 Purdue Research Foundation Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500289A (ja) * 2001-06-13 2005-01-06 マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド ラクトン処方物および使用方法
BRPI0620157A2 (pt) * 2005-12-15 2011-12-20 Activbiotics Pharma Llc usos de rifamicinas
US20210317099A1 (en) * 2020-04-09 2021-10-14 Purdue Research Foundation Safer, potent, and fast acting antimicrobial agents

Also Published As

Publication number Publication date
WO2022204231A3 (en) 2022-12-29
KR20230161962A (ko) 2023-11-28
CA3211535A1 (en) 2022-09-29
WO2022204231A2 (en) 2022-09-29
US20250339401A1 (en) 2025-11-06
EP4313040A2 (en) 2024-02-07
AU2022244356A1 (en) 2023-09-28
EP4313040A4 (en) 2025-02-12
JP2024511945A (ja) 2024-03-18

Similar Documents

Publication Publication Date Title
CN109963844B (zh) 一类抑制并降解酪氨酸蛋白激酶alk的化合物
CN1120153C (zh) 亚吡咯基甲基衍生物及其制备方法
US4532344A (en) Fluoranthene derivatives
CN110818648B (zh) 一种具有三氮唑侧链的截短侧耳素衍生物及其制备方法和应用
CN113149929A (zh) 一种具有1,3,4-恶二唑侧链的截短侧耳素衍生物及制备与应用
CN104211708B (zh) 苯并噁嗪酮衍生物及其作为抗菌剂的应用
CN1416428A (zh) 具有抗肿瘤活性的化合物、其制备方法以及含有该化合物的药物组合物
AU2006331676A1 (en) Nitroimidazole compounds
CN116283939B (zh) 一种具有光响应活性的抗真菌化合物及其应用
KR20230161962A (ko) 나이세리아 고노르호애의 치료 방법 및 재료
CN114957296B (zh) 一类新型阿尔茨海默病检测探针及其生物应用
CN107513089B (zh) 一种新型胞苷衍生物二聚体及其应用
JPH08509740A (ja) カンプトテシンの水溶性誘導体
JPH0114235B2 (cg-RX-API-DMAC7.html)
CN113563285A (zh) 一种新型重度抑郁症治疗药物伏硫西汀的制备方法
CN118724808B (zh) 四氢异喹啉类衍生物抗菌剂及其制备方法、包含其的组合物、药物制剂及三者的应用
JPS6183163A (ja) 抗腫瘍剤
CN116120327B (zh) β-榄香烯13,14-位对称的双取代衍生物及其制备方法和应用
CN119661519B (zh) 一种具有光动力抗菌作用的新型咔啉季铵盐类化合物的制备方法与应用
JP2002535276A (ja) 4−デメチルペンクロメジンのアシル誘導体、その使用及び調製
CN116589448B (zh) 一种3,4-二氢喹啉酮衍生物及其应用
RU2477127C1 (ru) Получение квартернизованных производных усниновой кислоты и их биологические свойства
EP1758904B1 (en) Flavopereirine derivatives for cancer therapy
US6660871B2 (en) Synthesis of 4H-chromene derivatives
EP1399455A2 (fr) Derives tricycliques de dihydroquinoleines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination